Investment Summary |
|
---|---|
Date | 2021-08-10 |
Target | Visus Therapeutics |
Sector | Life Science |
Investor(s) | EQT Life Sciences |
Deal Type | Venture |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Growth Capital Firm |
---|---|
Founded | 1987 |
PE ASSETS | 2.0B USD |
Size | Large |
Type | Sector Focused |
DEAL STATS | # |
---|---|
Overall | 39 of 47 |
Sector (Life Science) | 23 of 30 |
Type (Venture) | 33 of 39 |
State (Washington) | 1 of 1 |
Country (United States) | 9 of 11 |
Year (2021) | 7 of 12 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-07-21 |
binx health
Cambridge, Massachusetts, United States binx health is a healthcare technology and diagnostics company that makes routine testing convenient by enabling access to care where people live, work, study and shop. binx health was founded in 2005 and is based in Cambridge, Massachusetts. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-09-09 |
Evommune
Los Altos, California, United States Evommune is a biopharmaceutical company developing innovative therapies in the area of chronic inflammation, particularly in dermatological conditions. Evommune was founded in 2020 and is based in Los Altos, California. |
Buy | - |